Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,309 | 401 | 83.9% |
| Travel and Lodging | $2,836 | 16 | 15.5% |
| Consulting Fee | $83.58 | 1 | 0.5% |
| Education | $19.62 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,418 | 60 | $0 (2021) |
| Medtronic Vascular, Inc. | $1,861 | 30 | $0 (2019) |
| Boston Scientific Corporation | $1,494 | 21 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,365 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,045 | 34 | $0 (2024) |
| Cook Incorporated | $728.87 | 11 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $652.96 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $628.10 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $609.41 | 34 | $0 (2024) |
| Medtronic, Inc. | $549.16 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,471 | 80 | Novartis Pharmaceuticals Corporation ($241.35) |
| 2023 | $1,216 | 62 | E.R. Squibb & Sons, L.L.C. ($209.29) |
| 2022 | $1,591 | 68 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($258.18) |
| 2021 | $1,348 | 24 | Abbott Laboratories ($633.04) |
| 2020 | $361.64 | 9 | Boston Scientific Corporation ($148.31) |
| 2019 | $2,513 | 36 | Abbott Laboratories ($1,211) |
| 2018 | $4,528 | 63 | Abbott Laboratories ($2,418) |
| 2017 | $5,218 | 77 | Medtronic Vascular, Inc. ($1,183) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: DEVICES | ||||||
| 10/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Not Applicable | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardio-renal | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,828 | 2,549 | $823,953 | $238,720 |
| 2022 | 29 | 1,569 | 2,029 | $585,219 | $180,513 |
| 2021 | 13 | 430 | 577 | $124,421 | $41,425 |
| 2020 | 7 | 306 | 713 | $173,620 | $64,988 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 483 | $99,015 | $42,814 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 100 | 349 | $69,800 | $30,984 | 44.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 147 | 201 | $55,476 | $25,236 | 45.5% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 34 | 34 | $68,799 | $19,458 | 28.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 125 | 127 | $89,154 | $16,765 | 18.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 50 | 50 | $72,050 | $15,263 | 21.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 80 | 88 | $34,232 | $11,166 | 32.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 31 | $56,048 | $11,125 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 164 | 192 | $39,168 | $9,825 | 25.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 52 | 103 | $61,800 | $9,346 | 15.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 38 | 152 | $23,864 | $6,685 | 28.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 38 | 39 | $37,089 | $6,361 | 17.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $14,220 | $5,745 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,363 | $4,650 | 37.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 72 | $10,008 | $4,216 | 42.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $19,088 | $3,376 | 17.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 31 | 35 | $7,105 | $2,764 | 38.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $7,685 | $2,718 | 35.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 43 | 43 | $11,997 | $1,958 | 16.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 20 | 20 | $6,640 | $1,612 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $2,641 | $1,277 | 48.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 93 | 95 | $5,700 | $988.95 | 17.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 40 | 47 | $3,854 | $866.64 | 22.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 13 | $2,444 | $699.00 | 28.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 13 | 29 | $3,045 | $652.76 | 21.4% |
About Dr. Suraj Rao, MD
Dr. Suraj Rao, MD is a Cardiovascular Disease healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1336467018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suraj Rao, MD has received a total of $18,248 in payments from pharmaceutical and medical device companies, with $1,471 received in 2024. These payments were reported across 419 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($15,309).
As a Medicare-enrolled provider, Rao has provided services to 4,133 Medicare beneficiaries, totaling 5,868 services with total Medicare billing of $525,646. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Interventional Cardiology
- Location Aventura, FL
- Active Since 05/05/2010
- Last Updated 08/10/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336467018
Products in Payments
- Mitra Clip system (Device) $2,569
- CoreValve Evolut (Device) $1,850
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,224
- MitraClip System (Device) $779.26
- WATCHMAN (Device) $773.26
- ELIQUIS (Drug) $694.35
- LifeVest (Device) $652.96
- BRILINTA (Drug) $642.05
- Cook Medical Zilver PTX (Device) $577.68
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $546.76
- Perclose ProGlide suture mediated closure system (Device) $428.46
- LEQVIO (Drug) $343.85
- ELCAELCA X-80 (Device) $315.94
- Xience Alpine cornary stent system (Device) $304.65
- COMET (Device) $279.59
- ENTRESTO (Drug) $243.56
- Xience cornary stent systems (Device) $237.42
- COREVALVE EVOLUT R (Device) $219.20
- FARXIGA (Drug) $214.55
- VYNDAQEL (Drug) $213.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Aventura
Dr. Enrique Hanabergh, M.d, M.D
Cardiovascular Disease — Payments: $212,427
Ali Bazzi, Md, MD
Cardiovascular Disease — Payments: $86,627
Dr. Michelle Lister, Md, MD
Cardiovascular Disease — Payments: $11,699
Dr. Enrique Gorin, M.d, M.D
Cardiovascular Disease — Payments: $9,704
Heidar Arjomand-Fard, M.d, M.D
Cardiovascular Disease — Payments: $8,959
Leonard Pianko, M.d, M.D
Cardiovascular Disease — Payments: $8,856